Dr. C. Tuna Acne Blemish Control Serum

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with acne vulgaris, providing therapeutic benefits to manage and reduce the severity of this condition.

Dosage and Administration

Healthcare professionals are advised to apply 2 to 3 drops of the formulation once daily to the affected areas of clean skin. It is imperative to avoid application in the eye area to prevent irritation. Following the application of the drops, it is recommended to use Acne Balancing Cream to enhance treatment efficacy.

Contraindications

Use is contraindicated in patients with very sensitive skin or those who are sensitive to salicylic acid. Due to the potential for adverse reactions, individuals with these conditions should avoid this product.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients that skin irritation and dryness may be exacerbated when this product is used in conjunction with other topical acne treatments. To minimize the risk of irritation, it is recommended that patients use only one topical acne product at a time.

Patients should be cautioned to avoid sun exposure while using this product and to apply a broad-spectrum sunscreen to protect the skin. Additionally, contact with the eyes, lips, and mouth should be strictly avoided. In the event of accidental contact, patients should flush the affected area thoroughly with water. Signs of skin irritation, such as redness or tingling, may occur; should these symptoms intensify, patients are advised to discontinue use and seek medical advice.

In cases of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

This product is contraindicated for individuals with very sensitive skin or those who have a known sensitivity to salicylic acid.

Side Effects

Patients using this product may experience adverse reactions, which can vary in severity. Serious reactions include skin irritation and dryness, particularly when the product is combined with other topical acne skincare products. Skin irritation may manifest as redness or tingling; should these symptoms intensify, patients are advised to discontinue use and seek medical advice.

Common adverse reactions also include the potential for increased skin irritation. Patients are cautioned to avoid sun exposure and to use sunscreen to mitigate the risk of exacerbating skin sensitivity. Additionally, contact with the eyes, lips, and mouth should be avoided; in the event of contact, thorough flushing with water is recommended.

This product is for external use only. It should not be used by individuals with very sensitive skin or those who are known to be sensitive to salicylic acid. Furthermore, it is imperative to keep this product out of reach of children, as ingestion may necessitate immediate medical assistance or contact with a Poison Control Center.

Drug Interactions

Combining this product with other topical acne skincare products may increase the likelihood of skin irritation and dryness. To mitigate the risk of adverse effects, it is advised that only one topical acne skincare product be used at a time. If irritation occurs, discontinuation of the additional product is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when using multiple topical agents.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. C. Tuna Acne Blemish Control Serum (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The product has not been evaluated for safety in pregnancy. Salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. The use of salicylic acid during pregnancy may pose risks; therefore, it is essential for pregnant patients to consult a healthcare provider before use. No specific dosage modifications for pregnant individuals are provided; caution is advised when considering the use of this product in this population.

Lactation

There is no specific information regarding the use of Dr. C. Tuna Acne Blemish Control Serum in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as there is no available data to guide dosing or monitoring in this population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that they should not use the product if they have very sensitive skin or a known sensitivity to salicylic acid.

Healthcare providers should discuss the potential for skin irritation and dryness, particularly if the patient is using other topical acne skincare products concurrently. Patients should be instructed to use only one topical acne product at a time to minimize the risk of irritation.

Patients should be cautioned to avoid sun exposure while using this product and to apply a broad-spectrum sunscreen to protect their skin. Additionally, they should be informed to avoid contact with the eyes, lips, and mouth. In the event of accidental contact, patients should flush the area thoroughly with water.

It is essential to communicate that skin irritation may manifest as redness or tingling. If these symptoms worsen, patients should discontinue use and seek medical advice promptly.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are necessary beyond standard storage practices.

Additional Clinical Information

The product is administered topically, with a recommended application of 2-3 drops once daily on clean skin, avoiding the eye area. It is advised to follow the application with Acne Balancing Cream. Clinicians should counsel patients that the product is for external use only and that skin irritation and dryness may increase if combined with other topical acne treatments. In cases of irritation, patients should limit use to one topical acne product at a time.

Patients are also advised to avoid sun exposure and to use sunscreen. Contact with the eyes, lips, and mouth should be avoided; if contact occurs, the area should be flushed thoroughly with water. Symptoms of skin irritation, such as redness or tingling, may occur, and if these symptoms worsen, patients should discontinue use and seek medical advice. The product should be kept out of reach of children, and if ingested, medical assistance should be sought immediately. It is contraindicated for individuals with very sensitive skin or those who are sensitive to salicylic acid.

Drug Information (PDF)

This file contains official product information for Dr. C. Tuna Acne Blemish Control Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)